The AI & Machine Learning in Healthcare Conference will be returning for its 3rd year. This event has been designed to cater to a unique mix of stakeholders and will be attended by heads of innovation, clinicians, digital health and transformation managers, health informaticians, healthcare IT professionals.
The agenda will focus in on real insights on implementation and experiences in different and niche clinical settings. Radiology, Oncology, Pathology and hospital, surgery will be highlight how AI & Machine Learning can not only improve efficiencies but improve health outcomes for the patient and the medical practitioner.
Furthermore, the event will explore how clinicians and industry alike can leverage these emerging technologies to unlock opportunities for discovery and detection, enable greater accuracy, and provide the consumer with greater choice.
Governance, data, privacy, and legality issues will form the underlying theme of the conference. The event will ask the fundamental questions: who is responsible when AI does something? How is governance supporting innovation in healthcare? How do you find & address solutions to funding in the commercial space?
Finally, what will be next for AI & Machine Learning in healthcare? Have we finally moved away from ultimate knowledge and accepting AI & ML as decision assistance?
TOPICS TO BE ADDRESSED INCLUDE:
- Harnessing data to its full potential to enable the clinical application of AI in Canada
- The implementation of Radiology based AI in a clinical setting
- AI and Radiomics – The Future of Medical Imaging in Oncology
- Bringing AI into clinical practice within the pathology space
- Creating an AI Ecosystem at Metro South Hospital and Health Service
- How can clinicians and industry leverage these emerging technologies to drive efficiencies?
- Digital surgery 4.0 the next revolution: using AI & Robotics to drive efficiencies
- Machine learning in bio-medical image analysis
- Medical Device regulations: the ethical and regulatory framework in Australia
- How are hospitals investing in innovation?
- Privacy and data protection implications for AI in healthcare
- Permission based remote patient monitoring for detection and treatment
- The use of AI in high throughput Covid-19 drug screening and vaccine design
- Using AI for Clinical Trial Design
- How can the application of natural language processing and predictive modelling offer us in terms of better trial design & better ROI?
- Unlocking opportunities for discovery and detection in healthcare: hesitations & barriers for clinicians
- The Rise of the Healthcare Consumer – Driving a Better Experience for Patients
- What do cloud technologies add to genomics and Australian Healthcare?
- From Commercialisation to building a Hub to AI: what you need to know
- Navigating the funding path – finding & addressing solutions in the commercial space
- How do we ensure & enable greater accuracy?
Dr Nikolai Petrovsky
Professor, College of Medicine & Public Health, Flinders University, Chairman & Research Director, Vaxine
Dr Louise Sun
Cardiac Anaesthesiologist, AI Epidemiologist and Director of Big Data and Health Bioinformatics Research, University of Ottawa Heart Institute
Dr Terry Sweeney CMG
Chief Executive Officer, Digital Health Cooperative Research Centre
Associate Principal, Hive Legal
Professor Ian Scott
Director of Internal Medicine and Clinical Epidemiology, Princess Alexandra Hospital
Senior Associate, Hive Legal
Dr Carolyn Johnston
Research Fellow, University of Tasmania, Senior lecturer (honorary appointment) Melbourne Law School, Clinical Ethicist, Monash Children’s Hospital Melbourne
A/Prof Chris Hensman
General and Robotic Surgeon, Conjoint Lecturer, Monash University, University of Adelaide
Dr Stefan Harrer
Chief Innovation Officer, Digital Health CRC
Associate Professor Tam C. Nguyen
Deputy Director of Research, St Vincent's Hospital Melbourne
Chief Executive Officer, Opyl
Head of Innovation, Customer Engineering, Google
Bronwyn Le Grice
Founder, CEO & Managing Director, ANDHealth
Dr Greg Bass
Senior Scientist, CSL
Dr Michelle Perugini
Co-Founder and CEO, Presagen and Life Whisperer
Dr Hyun Soo Ko
Consultant Radiologist, MD, FRANZCR, Peter MacCallum Cancer Centre, Melbourne Epworth Medical Imaging, Epworth Freemasons Hospital, East Melbourne, Honorary Clinical Lecturer, University of Melbourne
CEO and Managing Director, LBT Innovations
Dr Ingmar Wahlqvist
Senior Investment Manager, Brandon Capital Partners
A/Prof Shlomo Berkovsky
Australian Institute of Health Innovation, Macquarie University
Dr Natalie Twine
Research Scientist and Genome Insights Team Lead, CSIRO
Dr Lee Walsh
Founder & Regulatory Principal, Platypus Technical, former Technical Lead (Digital Health), Therapeutic Goods Administration (TGA)
Founder & CEO, CareMonitor
Dr Johan Verjans
Deputy Director, Medical Machine Learning, Australian Institute of Machine Learning
Dr James Hughes
Lecturer and Researcher in the School of Nursing, QUT
Dr Paul Lane
Medical Director, Townsville University Hospital
Dr Rob Grenfell
Health Director, Health & Biosecurity, CSIRO
Dr Dean Ho
Head, Department of Biomedical Engineering, Director, The N.1 Institute for Health (N.1), Provost’s Chair Professor (Director, The Institute for Digital Medicine (WisDM)), National University of Singapore
Director, 3d Med Lab, Director, Department of Vascular Surgery, Austin Health
Informa Health & Safety
Informa Health & Safety Commitments
When you join our event, you can expect to see that health and safety is a priority, and that a range of measures are in place to ensure everyone involved is able to enjoy a safe, hygienic, productive and high-quality organised event experience.
All Informa events will be run according to official government and local authority guidance in the first instance, as well as any venue or location-specific regulations. In addition, Informa Australia will follow some key health and safety priority commitments as part of “Informa AllSecure”.
Vaccination required for all in-person attendees
To ensure the maximum safety of our audiences, Informa requires all in-person participants (speakers, delegates, partners, sponsors, exhibitors, suppliers) to be fully vaccinated in order to gain access to the physical event. For those unvaccinated or partially vaccinated, we encourage you to participate in the event by booking a virtual pass to attend the event.
This is an important measure to keep our community members safe who have not yet been able to get vaccinated or who are unable to get vaccinated. We hope it will also help infuse confidence and alleviate concerns that some may still have about attending an event in person.
For more information and to see our FAQs about our Covid-19 health & safety approach, please visit www.informa.com.au/allsecure
Event Health & Safety measures in place
- Informa will continue to adhere to the COVID-19 rules and restrictions applicable to the local state government where the event will be run
- Enhanced cleaning and hygiene practice including deep cleaning and sanitization before, during and after our events has been implemented.
- Reduced contact registration is in place
- Physically distanced seating options in line with local authority regulations will be provided in all venues
- Contact tracing: All attendees will be required to check-in to the event venue using the relevant government Covid-safe app
Conditions of entry:
Entry to an Informa event for attendees and staff is not permitted if they:
- are experiencing any cold or flu-like symptoms
- have been in close contact with a person who has tested positive for COVID-19
- are themselves, or residing with anyone who is, waiting the results of a test for COVID-19
- have returned from international or interstate (where relevant) travel and failed to observe the government requirement to quarantine for 14 days
- are not able to provide proof of vaccination
For more details please visit www.informa.com.au/healthsafety